iShares Biotechnology ETF $IBB Shares Sold by Whittier Trust Co.

Whittier Trust Co. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 7.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,609 shares of the financial services provider’s stock after selling 444 shares during the period. Whittier Trust Co.’s holdings in iShares Biotechnology ETF were worth $710,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of IBB. Citigroup Inc. raised its holdings in iShares Biotechnology ETF by 88.5% in the 1st quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock valued at $410,322,000 after buying an additional 1,505,976 shares during the period. Millennium Management LLC raised its holdings in iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after buying an additional 143,893 shares during the period. Jones Financial Companies Lllp raised its holdings in iShares Biotechnology ETF by 763.3% in the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock valued at $19,347,000 after buying an additional 133,744 shares during the period. Madrona Financial Services LLC raised its holdings in iShares Biotechnology ETF by 153.0% in the 1st quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock valued at $10,379,000 after buying an additional 49,075 shares during the period. Finally, Generali Investments CEE investicni spolecnost a.s. raised its holdings in iShares Biotechnology ETF by 35.0% in the 2nd quarter. Generali Investments CEE investicni spolecnost a.s. now owns 116,115 shares of the financial services provider’s stock valued at $14,690,000 after buying an additional 30,115 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $154.58 on Friday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $157.19. The company’s 50-day moving average price is $144.55 and its 200 day moving average price is $132.35.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 annualized dividend and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.